Ongoing studies in low-grade serous carcinoma
| Study name | Phase | Setting | Intervention | Identifier |
| NRG-GY019 | III | Adjuvant | Carboplatin/paclitaxel x6 followed by letrozole maintenance vs letrozole maintenance alone | NCT04095364 |
| LEPRE trial | III | Adjuvant | Carboplatin/paclitaxel x6 vs letrozole | NCT05601700 |
| MATAO | III | Adjuvant | Carboplatin/paclitaxel followed by letrozole vs placebo | NCT04111978 |
| GOG-3026 | II | Recurrent | Letrozole in combination with ribociclib | NCT03673124 |
| WO42178/ENGOT-GYN2/GOG-3051/BOUQUET | II | Recurrent | Multiple biomarker driven arms | NCT04931342 |
| II | Recurrent | Rogorafenib in combination with fulvestrant | NCT05113368 | |
| The FUCHSia Study | II | Recurrent | Fulvestrant | NCT03926936 |
| PERCEPTION | II | Recurrent | Carboplatin-based chemotherapy in combination with pembrolizumab | NCT04575961 |
| II | Recurrent | Liposomal doxorubicin in combination with peposertib | NCT04092270 | |
| ENGOT-ov60/GOG-3052/RAMP-201 | II | Recurrent | Avutometinib (VS-6766) in combination with defactinib | NCT04625270 |